The effect of changes in intraocular pressure on the risk of primary openangle glaucoma in patients with ocular hypertension: an application of latent class analysis.  
Jump to Full Text  
MedLine Citation:

PMID: 23035867 Owner: NLM Status: MEDLINE 
Abstract/OtherAbstract:

BACKGROUND: Primary openangle glaucoma (POAG) is one of the leading causes of blindness in the United States and worldwide. While lowering intraocular pressure (IOP) has been proven to be effective in delaying or preventing the onset of POAG in many largescale prospective studies, one of the recent hot topics in glaucoma research is the effect of IOP fluctuation (IOP lability) on the risk of developing POAG in treated and untreated subjects. METHOD: In this paper, we analyzed data from the Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS) for subjects who had at least 2 IOP measurements after randomization prior to POAG diagnosis. We assessed the interrelationships among the baseline covariates, the changes of postrandomization IOP over time, and the risk of developing POAG, using a latent class analysis (LCA) which allows us to identify distinct patterns (latent classes) of IOP trajectories. RESULT: The IOP change in OHTS was best described by 6 latent classes differentiated primarily by the mean IOP levels during followup. Subjects with high postrandomization mean IOP level and/or large variability were more likely to develop POAG. Five baseline factors were found to be significantly predictive of the IOP classification in OHTS: treatment assignment, baseline IOP, gender, race, and history of hypertension. In separate analyses of EGPS, LCA identified different patterns of IOP change from those in OHTS, but confirmed that subjects with high mean level and large variability were at high risk to develop POAG. CONCLUSION: LCA provides a useful tool to assess the impact of postrandomization IOP level and fluctuation on the risk of developing POAG in patients with ocular hypertension. The incorporation of postrandomization IOP can improve the overall predictive ability of the original model that included only baseline risk factors. 
Authors:

Feng Gao; J Philip Miller; Stefano Miglior; Julia A Beiser; Valter Torri; Michael A Kass; Mae O Gordon 
Related Documents
:

6469787  Model analysis of tidal volume response to inspiratory elastic loads. 24089867  Twin sample chamber for simultaneous comparative transport measurements in a diamond an... 23249707  Profiles of intraocular pressure in human donor eyes during femtosecondlaser procedure... 8255637  The effect of instrumental dead space on measurement of breathing pattern and pulmonary... 15660047  Determinants of functional capacity in patients with chronic heart failure: role of fil... 25165067  Mthfr c677t polymorphism affects normotensive diastolic blood pressure independently of... 
Publication Detail:

Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, NonU.S. Gov't Date: 20121004 
Journal Detail:

Title: BMC medical research methodology Volume: 12 ISSN: 14712288 ISO Abbreviation: BMC Med Res Methodol Publication Date: 2012 
Date Detail:

Created Date: 20121231 Completed Date: 20130620 Revised Date: 20131107 
Medline Journal Info:

Nlm Unique ID: 100968545 Medline TA: BMC Med Res Methodol Country: England 
Other Details:

Languages: eng Pagination: 151 Citation Subset: IM 
Affiliation:

Division of Biostatistics, Washington University School of Medicine, St, Louis, MO, 63110, USA. feng@wustl.edu 
Export Citation:

APA/MLA Format Download EndNote Download BibTex 
MeSH Terms  
Descriptor/Qualifier:

Blindness Cohort Studies Female Glaucoma, OpenAngle / diagnosis*, etiology* Humans Intraocular Pressure / physiology* Male Middle Aged Ocular Hypertension* Risk Factors Survival Tonometry, Ocular Visual Fields 
Grant Support  
ID/Acronym/Agency:

EY091369/EY/NEI NIH HHS; EY09341/EY/NEI NIH HHS 
Comments/Corrections 
Full Text  
Journal Information Journal ID (nlmta): BMC Med Res Methodol Journal ID (isoabbrev): BMC Med Res Methodol ISSN: 14712288 Publisher: BioMed Central 
Article Information Download PDF Copyright ©2012 Gao et al.; licensee BioMed Central Ltd. openaccess: Received Day: 21 Month: 10 Year: 2011 Accepted Day: 25 Month: 9 Year: 2012 collection publication date: Year: 2012 Electronic publication date: Day: 4 Month: 10 Year: 2012 Volume: 12First Page: 151 Last Page: 151 PubMed Id: 23035867 ID: 3532135 Publisher Id: 1471228812151 DOI: 10.1186/1471228812151 
The effect of changes in intraocular pressure on the risk of primary openangle glaucoma in patients with ocular hypertension: an application of latent class analysis  
Feng Gao1  Email: feng@wustl.edu 
J Philip Miller1  Email: phil@wubios.wustl.edu 
Stefano Miglior3  Email: stefano.miglior@unimib.it 
Julia A Beiser2  Email: Julia@vrcc.wustl.edu 
Valter Torri4  Email: torri@marionegri.it 
Michael A Kass2  Email: Kass@vision.wustl.edu 
Mae O Gordon12  Email: Mae@vrcc.wustl.edu 
1Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, 63110, USA 

2Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA 

3Department of Ophthalmology, The Policlinico di Monza, University Bicocca of Milan, Milan, Italy 

4Laboratory of New Drugs Development Strategies, Mario Negri Institute, Milan, Italy 
Ocular hypertension is a leading risk factor for the development of primary openangle glaucoma (POAG) which remains one of the major causes of blindness in the United States and worldwide [^{1}^{}^{5}]. It is estimated that approximately 4%  7% of the population over the age of 40 years have ocular hypertension without detectable glaucomatous damage using standard clinical tests, and thus as many as 3 to 6 million Americans are at risk for developing glaucoma because of ocular hypertension [^{6}^{}^{8}]. Intraocular pressure (IOP) is the only known modifiable risk factor for POAG. Lowering the level of IOP has been shown to effectively delay or prevent glaucomatous visual damage in different phases of disease progression by many largescale multicenter clinical trials, including the Ocular Hypertension Treatment Study (OHTS) [^{9}], the Early Manifest Glaucoma Trial [^{10}], and the Advanced Glaucoma Intervention Study [^{11}].
In recent years, one of the hot topics in glaucoma research has been the effect of IOP fluctuation (IOP lability), both within a single day (shortterm fluctuation) and from visit to visit (longterm fluctuation) on POAG [^{12},^{13}]. Measures of IOP fluctuation have included a wide range of quantities  peak, trough, variance, and range, etc. [^{13}] However, since subjects with high mean IOP often show large IOP variability over time, it is challenging to disentangle the effect of fluctuation from mean IOP. A recently emerged technique for longitudinal data analysis, latent class analysis (LCA) [^{14}], provides an appealing approach to this question. Rather than dealing with individual measures of fluctuation, LCA identifies distinct patterns of longitudinal profiles based on the combination of summary statistics (i.e., mean level and variability) and hence provides information complementary to the conventional methods. LCA uses the patterns of serial biomarker readings available for subjects, together with baseline covariates and disease outcomes, to divide subjects into a number of mutually exclusive subpopulations (classes). The class membership is unobserved (latent) and determined by the classspecific parameters in a datadriven basis.
In this paper, we used LCA to model the postrandomization IOP in the OHTS. For each class, the change of IOP was characterized by 4 parameters: the initial IOP level (I), the linear (L) and quadratic (Q) trend over time, and the variance of IOP (V). We used data from the European Glaucoma Prevention Study (EGPS) [^{15}], another largescale multicenter randomized clinical trial of patients with ocular hypertension, for external independent validation. We first fit an unconditional (without any covariates) LCA to determine the optimal number of distinct patterns that best described the IOP change for each study. Then a conditional model was constructed by adding baseline covariates as the antecedents (predictors) of IOP change and time to POAG as a consequence (outcome) of IOP change [^{16}]. This analysis enhanced our understanding of the interrelationships among the IOP change, the baseline covariates, and the risk of developing POAG. This also provided evidence towards our ultimate goal to improve the prediction of POAG in patients with ocular hypertension.
Our study used data from OHTS and EGPS, the two largest randomized trials to test safety and efficacy of topical hypotensive medication in preventing the development of POAG. In OHTS, 1636 subjects were randomized to either observation or treatment with ocular hypotensive medication and followed for a median of 78 months [^{9}]. In EGPS, 1077 subjects were randomized to either placebo or an active treatment (dorzolamide) and followed for a median of 55 months [^{15}]. The two studies shared many key similarities in the study protocol and generated data of high quality. In both studies, for example, the outcome ascertainment was performed by specialized resource centers where readers were masked as to randomization assignment and information about the participant’s clinical status, and the attribution of abnormality due to POAG was performed by a masked Endpoint Committee. Detailed information on the similarity and discrepancy between OHTS and EGPS as described by Gordon et al. [^{17}]. This study was approved by the Institutional Review Boards of Washington University in St. Louis and the University Bicocca of Milan.
In this paper, we excluded IOP values measured after POAG onset. The primary endpoint was time from randomization to the development of POAG. Those subjects who did not develop POAG were censored at the date of study closeout. In addition to the followup data, following 13 demographic and clinical characteristics at randomization were also included in this paper: treatment assignment (TRT, 0 for observation/placebo and 1 for treatment), male gender (Male), black race (Black), age at randomization (Age, decade), baseline IOP (IOP0, mmHg), central corneal thickness (CCT, μm), pattern standard deviation (PSD, dB), vertical cup/disc ratio (VCD), the use of systematic beta blocker (BB) or Calcium channel blockers (CHB), and the history of diabetes (DM), heart diseases (Heart), or hypertension (HBP). These baseline factors were identified a priori as possible predictors for the development of POAG during the planning phase of the OHTS [^{18}]. We excluded 34 subjects from EGPS with pigment dispersion and exfoliation syndromes (an exclusion criterion in OHTS). We also excluded subjects without any followup data (18 in OHTS and 47 in EGPS) or those with only 1 followup visit (19 in OHTS and 25 in EGPS). Therefore, these subjects with at least 2 followup visits (1600 from OHTS and 971 from EGPS) constituted our study cohort for the unconditional LCA. In the conditional LCA, we further excluded subjects without CCT measurements (169 in OHTS and 143 in EGPS) or those with missing values in any other baseline factors (6 in EGPS). Table 1 presented the summary statistics of baseline covariates and postrandomization data for each study, where the binary data were summarized as counts and proportions, while the continuous variables were summarized in means and standard deviations (SD). For consistency with previous analyses [^{17},^{18}], values for the baseline eyespecific variables (CCT, PSD, VCD, and baseline IOP) for each participant were the average of two eyes (with the exception of the EGPS participants with only one eye eligible for the study). For the postrandomization IOP, however, only eyespecific data were used because averaging two eyes could underestimate the true intrapatient IOP variability. We took advantage of the fact that IOPs between two eyes were highly correlated (with an intraclass correlation coefficient of 0.75), and followup IOPs were chosen from the first eye developed POAG or an eye selected randomly in participants without POAG. Since the continuous baseline covariates were measured in quite different scales, they were standardized to have mean 0 and variance 1 throughout the remainder of this paper. As such, for these variables the odds ratios (OR) and hazard ratios (HR) from the regression models represented the effect per 1SD change.
Suppose there were N subjects and each subject had n_{i} prePOAG IOP measures. Let Y_{i} = {Y1, Y2, ……} denote the postrandomization IOP and C_{i} represent the latent class membership of i^{th} individual, and θ_{g} be the vector of classspecific parameters that differentiate the G latent classes, with i =1, 2, …,N, and g =1, 2, …,G, respectively. Then the distribution of Y_{i} was a mixture distribution defined as [^{14}],
(1)
fYi=∑g=1G{PrCi=g·fYiCi=g;θg} 
where PrCi=g represented the size (mixing proportion) of g^{th} latent class in the mixture and fYiCi=g;θg was the classspecific distribution of Y_{i} as detailed below.
• The mixing probability PrCi=g was modeled as a multinomial logistic regression, PrCi=g=expα0g∑h=1Gexpα0g, where α_{0g} represented the log odds of membership in the g^{th} class relative to a reference class (class 1, say), with the parameter in the reference being 0 for identification.
• The specification of fYiCi=g;θg was aided by our previous experience on the joint modeling of longitudinal IOP and time to POAG in OHTS [^{19}]. The joint model identified IOP variability as an independent predictor for POAG and also revealed that the IOP change can be better fit by a quadratic functional form. Therefore, we set fYiCi=g;θg=Ig+Lgti+Qgti2+εi_{,} with εi~N(0, Vg)andθg=Ig,Lg,Qg,Vg. Because high IOP was an eligibility criterion in both OHTS and EGPS, the estimated initial level (intercept I_{g}) may be influenced by “regression to the mean”. To address this concern, we reset the time 0 and the intercept was actually estimated at 1year after randomization. We also assumed that followup IOPs were measured regularly every 6 months according to the protocol, i.e., with timing t_{i} = {−0.5, 0, 0.5, 1, …}. Figure 1A showed the diagram of an unconditional LCA for the OHTS data.
• Given the estimated parameters θ⌢g and the observed IOP, each individual can be assigned to the most likely class based on the probability of class membership (often termed as posterior class probability) [^{14}],
•
(2)
pig=P⌢rCi=g·f(YiCi=g;θ⌢g)∑h=1G{P⌢rCi=h·fYiCi=h;θ⌢h}. 
The best unconditional LCA was selected by enumerating and comparing a set of competing models differing only in the number of classes. In this paper, the model comparison was based primarily on the log likelihood values, including the Bayesian Information Criteria (BIC, with a smaller BIC indicating a better fit) and the LoMendellRubin adjusted likelihood ratio test (LMRLRT) [^{20}]. A significant test of LMRLRT indicated that the model with G1 classes should be rejected in favor of the Gclass LCA. In addition to the above statistical criteria, we also specified a minimum size for each class (with at least 5% participants in OHTS or 10% participants in EGPS) to ensure reliable withinclass estimation. Once an optimal LCA was developed, a bootstrap method was used to assess whether patients with different patterns of IOP change have different susceptibility to POAG. Specifically, a class membership was generated for each individual from a multinomial distribution using the posterior class probability, and then a Cox model was fit to assess the effects of latent classes on POAG. Summary statistics such as hazard ratios and their 95% confidence intervals were estimated by repeating the above procedure 1,000 times.
Since patterns of IOP change were found to be associated with the risk of POAG in an unconditional LCA, a conditional LCA was built by adding baseline covariates as predictors to the IOP change and adding time to POAG as an outcome due to IOP change (Figure 1B). Let X_{i} denote the baseline predictors for i^{th} subject and T_{i} = minimum(D_{i}, U_{i}) be the observed time, where D_{i} was the time to POAG and U_{i} represented the censoring time independent of D_{i} . Let Δ_{i} be the corresponding event indicator, with Δ_{i} = 1 if POAG is observed and Δ_{i} = 0 otherwise. Let α and β denote effects of baseline covariates X_{i} on the IOP change and time to POAG respectively. Then the joint distribution of (Y_{i}, T_{i}) was a mixture distribution defined as [^{21}],
(3)
fYi,Ti=∑g=1G{PrCi=g;αg·f(YiCi=g;θg)•λTiCi=g;βΔi·S(TiCi=g;β)} 
• Similar to Model (1), the term PrCi=g;αg=expα0g+αgXi∑h=1Gexp(α0h+αhXi) represented the size of g^{th} class in the mixture distribution and fYiCi=g;θg described the withinclass IOP change.
• The term λTiCi=g;β=λ0g(t)·expβXi described the risk of developing POAG in g^{th} class and S(TiCi=g;β)=exp(−∫λ0g(t)·exp(βXi(dt) was the corresponding cumulative POAGfree probability, where λ_{0g}(t) was the classspecific baseline hazard with all covariates being 0. In this paper, λ_{0g}(t) was approximated by a piecewise stepfunction with a 6month interval. Following the conventional practice in joint latent class modeling [^{21},^{22}], we assumed that the association between IOP change and time to POAG was introduced exclusively via λ_{0g}(t), so that the longitudinal process and survival process were completely independent given the class membership. Therefore, neither timedependent IOP values nor random effects of IOP were included in the survival function. We also assumed that the effects of covariates on POAG were common across latent classes.
The conditional LCA facilitated a better understanding of ocular hypotensive treatment on the risk of developing POAG. This model allowed us to determine whether the predictive accuracy on POAG can be improved by adding postrandomization IOP. For example, the survival probability (cumulative POAGfree rate) at any time t can be readily calculated as the average of the classspecific survival weighted by the posterior class probabilities,
(4)
S(Ti=t)=∑g=1Gp^ig·S^(Ti=tCi=g;β^) 
(5)
withp^ig=P⌢rCi=g;α^g·f(YiCi=g;θ⌢g)∑h=1G{P⌢rCi=h;α^h·fYiCi=h;θ⌢h}, 
(6)
andS^(Ti=tCi=g;β^)=exp(−∫s=0tλ^0g(s)·expβ^Xids), 
where (θ^g,α^g,β^,andλ^0g(t)) were the estimated parameters from the conditional LCA. In this paper, the parameter estimation for LCA was implemented using statistical package Mplus [^{23}], while all the other analyses were performed using statistical package R [^{24}].
Table 2 showed the fitting statistics of 7 competing LCAs for the OHTS and EGPS data. Based on the modelselection criteria, the IOP change in OHTS was best described by 6 distinct patterns (latent classes), which included 13%, 28%, 20%, 10%, 18% and 11% of the OHTS subjects respectively. Figure 2 showed the followup IOPs of 50 randomly selected subjects for each class. Most classes were distinguished primarily by the mean IOP levels. The only exceptions were classes 3 and 4. Classes 3 and 4 had similar average trajectories, but subjects in Class 4 showed a much larger variability. Figure 2 also indicated that the classes with higher mean level and/or larger variability had a higher risk of developing POAG. Table 3 reported the observed frequency of POAG in each class based on the most likely class membership. The hazard ratio (HR) and its 95% confidence interval (CI) of developing POAG in each class were also calculated using 1000 bootstrapping samples to account for the uncertainty in class membership. The results showed that the last 3 classes had significantly higher risk of developing POAG than the first 3 classes. For reasons that were not clear, however, subjects in Class 2 had the smallest risk though the subjects in Class 1 had the lowest mean followup IOP.
In EGPS, the IOP change was best fit by a 5class LCA (Table 2). Figure 3 showed the postrandomization IOPs of 50 randomly selected subjects from each of the 5 classes, which included 25%, 19%, 28%, 16% and 12% of EGPS subjects respectively. Subjects in classes 1 and 2 started with similar initial followup IOP levels, but those in Class 2 showed a relatively rapid decrease over time. Similarly, subjects in classes 3 and 4 had similar initial levels, but subjects in Class 4 showed a relatively rapid decrease and subjects in Class 3 did not. All subjects in the first 4 classes presented similar magnitude of IOP variability. Subjects in Class 5 had the highest mean level and the largest variability, and they showed a significantly higher risk than the other 4 classes (Table 3).
Table 4 presented the distribution of treatment groups across latent classes in the OHTS and EGPS data respectively. In OHTS a great majority of subjects from treatment group fell into the first 3 classes, while in EGPS the distributions of treatment groups were rather similar across all latent classes.
A conditional model was constructed for OHTS and EGPS separately by adding the baseline factors as predictors and the time to POAG as the outcome to the optimal unconditional LCAs (Figure 1B). Since we had an adequate sample size in both studies, no variableselection procedure was performed and all the baseline covariates (with the exception of dropping the variable race Black from EGPS because of lack of racial diversity) were included as predictors for both IOP change and the risk of developing POAG. Figure 4 presented the modelbased predicted cumulative incidence for an “average” person with all baseline covariates being zero. After controlling for baseline covariates, different patterns of IOP change continued to be prognostic of POAG development. In both studies, the class with the highest mean level was most likely to develop POAG after adjusting for baseline IOP. In OHTS, subjects in Class 4 (with a moderate mean IOP and the largest variability) had similar risk as those in Class 5 (with a higher mean IOP and much less variability), but showed a higher risk than those in Class 3 (with the mean IOP comparable to Class 4 but with much less variability). In EGPS, the first 4 classes showed similar risk of developing POAG.
Table 5 presented the estimated parameters for withinclass IOP trajectories, as well as the effects of baseline covariates on IOP classification and the risk of POAG development.
• To identify baseline predictors for IOP classification, we only focused on factors that were significantly associated with the high risk groups (Classes 4, 5, 6 in OHTS, and Class 5 in EGPS), while treating the lowest risk group (Class 2 in OHTS and Class 1 in EGPS) as the reference. In OHTS, treatment assignment and baseline IOP were two most important predictors for IOP classification. Subjects randomized to treatment group had a much lower chance of inclusion in the high risk groups (with OR = 0.11, 0.003, and 0.002 for Classes 4, 5, and 6, respectively), while these with a higher baseline IOP were more likely to be in the Classes 4, 5, or 6 (with OR = 2.80, 2.44, and 5.64 respectively). The results also showed that male subjects were less likely to be in Class 5 (OR = 0.51), the black subjects were more likely to be in Class 4 (OR = 2.12) but with a lower chance in Class 5 (OR = 0.40), and subjects with a history of hypertension were more likely in Class 6 (OR = 1.93). In EGPS, the results confirmed that treatment assignment (OR = 0.17) and baseline IOP level (OR = 5.99) were important predictors for Class 5. The result also showed that older age (OR = 1.57) was significantly associated with Class 5.
• As expected, the effects of baseline covariates on the risk of developing POAG from the conditional LCA reached consistent conclusions as previous analyses using Cox models [^{17},^{25}]. In OHTS, subjects with older age (HR = 1.20), higher PSD (HR = 1.26), large VCD (HR = 1.82), and history of heart diseases (HR = 2.03) had a higher risk of developing POAG, while thicker CCT (HR = 0.53) and history of diabetes (HR = 0.19) reduced the risk of developing POAG. Interestingly, despite marked differences between OHTS and EGPS in the patterns of IOP change, the EGPS confirmed 4 of the 6 predictors (except age and history of diabetes) identified in OHTS. In both studies, baseline IOP and treatment assignment were not significantly associated with POAG directly, but appeared to affect the risk indirectly through their strong influence on the classification of IOP change.
To explore the effect of followup IOP on the overall predictive accuracy of POAG, the 5year cumulative POAG incidence was calculated for each individual using the formula (3). The overall predictive accuracy was summarized as Cindex and calibration statistics (Model 1 in Table 6) [^{26}]. For comparison, Table 6 also presented the Cindex and calibration statistics from Cox models that only incorporated baseline predictors (Model 0). The results showed that adding postrandomization IOP considerably improved the predictive accuracy on POAG. In OHTS, for example, Cindex increased from 0.778 to 0.821 by adding followup IOP. Given the fact that Cindex from the baseline model was already high and there was little room for improvement, such an increase was substantial. An improvement in the Cindex was also observed in EGPS though in a much smaller magnitude (from 0.706 to 0.719). The calibration statistics indicated that the modelbased and observed survival probabilities were well agreed in both OHTS (X^{2} = 11.3) and EGPS (X^{2} = 7.0).
As in all the statistical models, LCAs were inevitably based on certain assumptions. One assumption of our LCA was that the trajectories of IOP followed a quadratic functional form. It is known that the parameter estimates, class sizes, and interpretation of latent classes could be heavily influenced by the withinclass distribution of longitudinal data [^{16}]. In this section, first we assessed the sensitivity of risk prediction to different LCA specifications. Table 6 presented the Cindex and calibration statistics for LCAs after removing the quadratic term (Model 2) or removing both quadratic and linear terms (Model 3). The results showed that LCAs had a robust performance in terms of predictive accuracy for POAG development.
Next, two additional sensitivity analyses were performed in the OHTS data, one excluding participants with Black race and the other only using participants randomized to the observation group. The IOP change in the nonBlack was best described by 6 distinct classes, while the LCA in the untreated participants identified 5 classes. Figures 5A and 5C showed the observed mean IOP of latent classes in the nonBlack and untreated participants, respectively. Although most classes were distinguished primarily by the mean IOP, each LCA identified a subgroup of participants (Class 4) who had a moderate IOP mean but with the highest IOP variability. More interestingly, the participants from Class 4 in both LCAs showed relatively higher risk of POAG development than those with a comparable mean IOP (Figures 5B and 5D).
Finally, our LCA also made an implicit assumption that the baseline covariates influenced the IOP change exclusively through their effects on the class membership (i.e., no direct effects on the withinclass growth parameters). The validity of this assumption can be checked by comparing the conditional LCAs with the unconditional models. The assumption violation is often signified by a dramatic shifting in the meaning and size of latent classes when the baseline predictors are added to the unconditional LCA [^{16}]. Based on the estimated classspecific parameters (Table 5, Figures 2 and 3), this assumption was well satisfied in both studies.
In recent years, one of the hot topics in glaucoma research has been the effect of IOP fluctuation on POAG. Although more and more studies have confirmed that a decrease in the mean IOP level can reduce the risk of developing POAG, the findings from major prospective clinical trials about the impact of IOP fluctuation on POAG remain controversial [^{25},^{27}^{}^{30}]. In this paper, we analyzed the postrandomization IOPs from OHTS and EGPS taking a latent class analysis (LCA) approach. The LCA allows us to identify distinct patterns of IOP change over time and then associates the changes in IOP with the risk of POAG. The results from both studies showed that different patterns of IOP change could markedly affect the risk of POAG (irrespective of their baseline, prerandomization IOP levels). In OHTS, the change in IOP was best described by 6 distinct patterns. The model identified a subset of participants in whom IOP variability also played an important role in predicting POAG. This subgroup showed the highest IOP variability and had a higher risk than those with a comparable IOP mean. Comparing to the reference class, these participants were less likely from treatment group (OR = 0.11), more likely selfclassified as being black (OR = 2.12), and had relatively higher baseline IOP (OR = 2.80). However, the subgroup only accounted for about 10% of the OHTS sample, and this may partially explain our finding that IOP variability was an independent risk factor in the OHTS but had little impact on the overall predictive accuracy for POAG (manuscript in progression). In a sensitivity analysis using the nonBlack participants, the LCA identified similar patterns of IOP change as in the whole OHTS dataset. This result was consistent with a treebased model in the OHTSEGPS metaanalysis which showed that race was no longer an important predictor for POAG development after considering other risk factors [^{17}]. In EGPS, LCA identified 5 distinct latent classes and confirmed that those subjects with the highest mean IOP were most likely to develop POAG. However, it failed to disentangle the effect of fluctuation from mean because these participants with the highest mean level also had the largest IOP variability. Interestingly, despite the marked differences between EGPS and OHTS in the treatment intervention and magnitude of IOP lowering achieved, both studies showed that adding IOP change into the baseline model improved the overall predictive accuracy for POAG development.
Conventionally the change of longitudinal data is described using linear mixed models with random coefficients [^{31}]. Though the mixed model recognizes the heterogeneous nature of the data by allowing each individual to have his/her own intercept and slope, it assumes that all individuals come from a single population and uses an average trajectory for the entire population. A LCA analyzes data from a rather different perspective. The model approximates the unknown heterogeneity in the distribution of longitudinal outcome using a finite number of polynomial functions each describing a unique subpopulation [^{14},^{32}]. It classifies individuals into distinct groups based on the patterns of longitudinal outcome, so that individual within a group are more similar than those between different groups. This LCA possesses some unique advantages as comparing to conventional methods. First, the model lends itself directly to a set of well characterized subpopulations and also provides a formal statistical procedure to determine the appropriate number of subpopulations. It thus enables the discovery of unexpected yet potentially meaningful subpopulations that may be otherwise missed with conventional methods. Second, the method permits one to relate the developmental patterns of longitudinal data to its antecedents (predictors or covariates) and consequences (clinical outcomes), and thus allows estimation of both direct and indirect (via longitudinal data) effects of a covariate on the distant outcome [^{16},^{23}]. Finally, the recent advances of the dual trajectory modeling also allow investigators to assess the joint evolution of multiple longitudinal processes, which may evolve contemporaneously or over different time periods [^{32}].
LCA also provides an attractive alternative for making prediction with timedependent covariates [^{21},^{22}]. A LCA takes a joint modeling approach to assess the association between longitudinal and survival data and thus uses information more efficiently, resulting less biased estimates. Unlike the conventional joint models that assess the association via shared random effects [^{19},^{33},^{34}], a LCA relates the longitudinal process to survival process by latent classes and assumes the two stochastic processes independent given the class membership [^{22}]. Therefore, neither timedependent covariates nor random effects of the longitudinal data are needed in the survival submodel. Such a model specification will avoid the intensive computation to obtain the random effects for new subjects and hence facilitates a realtime individualized prediction [^{21}]. The key to build an accurate prediction in a LCA setting is to have a reliable classification given the observed data. Generally speaking, the more the available serial biomarker readings, the more reliable a classification is. To this consideration, the impact of followup IOP on POAG may be overestimated in OHTS because an average length of 6.5year IOP readings was used to calculate the 5year POAGfree rate. To solve this dilemma, which is rather common in all predictions involving timedependent covariates, one of the most frequently used approaches in medical literature is a landmark analysis that consists of fitting a serial of survival models only to the subjects still at risk, that is, computation of the predictive distribution at a certain time given the history of event and covariates until that moment [^{35}]. In a LCA setting, such a dynamic prediction can be conveniently implemented because the conditional survival probability at any time can be calculated analytically from a single LCA once the parameters are estimated [^{21}].
Despite its advantages, the LCA has several limitations. First, the computational load of LCA can be high, especially for models with complexity structures. In OHTS data (N = 1600), for example, it ran less than 10 minutes for an unconditional 6class LCA, but it took more than 30 minutes to develop the full conditional model. Because of the exploratory nature of data analysis with LCA, the cumulative time can be substantial. For this consideration, in practice the best LCA model is often constructed taking a twostep approach as in this paper. Another issue in LCA is that the loglikelihood function may end up at local rather than global maxima. Fortunately this issue has been taken into consideration by the statistical package Mplus which automatically uses 10 sets of randomly generated starting values for estimation. The program also allows investigators to rerun and compare the estimates from user specified starting values if necessary [^{23}].
LCA provides a useful alternative to understand the interrelationship among the baseline covariates, the change in followup IOP, and the risk of developing POAG. The inclusion of postrandomization IOP can improve the predictive ability of the original prediction model that only included baseline risk factors.
IOP: Intraocular pressure; POAG: Primary openangle glaucoma; LCA: Latent class analysis; OHTS: The ocular hypertension treatment study; EGPS: The european glaucoma prevention study; HR: Hazards ratio; OR: Odds ratio; CCT: Central corneal thickness; PSD: Pattern standard deviation; VCD: Vertical cup/disc ratio.
The authors declare that they have no competing interests.
FG, JPM, JAB and MOG conceived the study. FG and JAB carried out the data analysis. FG and MOG drafted the first version of the manuscript. All authors contributed to the critical review and approved the final version.
The prepublication history for this paper can be accessed here:
http://www.biomedcentral.com/14712288/12/151/prepub
This study is supported by grants from the National Eye Institute of Health (EY091369 and EY09341) and Research to Prevent Blindness (RPB).
References
Quigley HA,Number of people with glaucoma worldwideBr J OphthalmolYear: 199680538939310.1136/bjo.80.5.3898695555  
Sommer A,Tielsch JM,Katz J,et al. Racial differences in the causespecific prevalence of blindness in east BaltimoreN Engl J MedYear: 1991325201412141710.1056/NEJM1991111432520041922252  
US Department of Health, Education, and WelfareStatistics on blindness in the model reporting area 1969–1970Year: 1973Washington, DC: US Government Printing Office  
Quigley HA,Vitale S,Models of openangle glaucoma prevalence and incidence in the United StatesInvest Ophthalmol Vis SciYear: 199738183919008633  
Hyman L,Wu SY,Connell AM,et al. Prevalence and causes of visual impairment in the Barbados eye studyOphthalmologyYear: 2001108101751175610.1016/S01616420(01)00590511581045  
Leibowitz HM,Krueger DE,Maunder LR,et al. The Framingham Eye study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975Surv OphthalmolYear: 198024suppl3356107444756  
Armaly MF,Kreuger DE,Maunder L,et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visualfield defectsArch OphthalmolYear: 1980982163217110.1001/archopht.1980.010200410150027447768  
Quigley HA,Enger C,Katz J,et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertensionArch OphthalmolYear: 199411264464910.1001/archopht.1994.010901700880288185522  
Kass MA,Heuer DK,Higginbotham EJ,et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucomaArch OphthalmolYear: 20021206701713 discussion 829–830. 12049574  
Heijl A,Leske MC,Bengtsson B,et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trialArch OphthalmolYear: 2002120101268127912365904  
The Advanced Glaucoma Intervention Study GroupThe advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J OphthalmolYear: 200013042944011024415  
Singh K,Shrivastava A,Intraocular pressure fluctuations: how much do they matter?Curr Opin OphthalmolYear: 200920848710.1097/ICU.0b013e328324e6c419248311  
Sultan MB,Mansberger SL,Lee PP,Understanding the importance of IOP variables in glaucoma: a systematic reviewSurv OphthalmolYear: 20095464366210.1016/j.survophthal.2009.05.00119665744  
Nagin DS,Groupbased modeling of developmentYear: 2005Cambridge: MA. Harvard University Press  
Miglior S,Pfeiffer N,Torri V,Zeyen T,CunhaVaz J,Adamsons I,Predictive factors for openangle glaucoma among subjects with ocular hypertension in the European glaucoma prevention studyOphthalmologyYear: 200711413917070596  
Petras H,Masyn K,General growth mixture analysis with antecedents and consequences of changeYear: 2009Springer: Handbook of Quantitative Criminology  
Gordon MO,Torri V,Miglior S,Beiser JA,Floriani I,Miller JP,Gao F,Adamsons I,Poli D,D’Agostino RB,Kass MA,The ocular hypertension treatment study group and the European glaucoma prevention study group. A validated prediction model for the development of primary open angle glaucoma in individuals with ocular hypertensionOphthalmologyYear: 20071141101917095090  
Gordon MO,Beiser JA,Brandt JD,Heuer D,Higginbotham E,Johnson C,et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary openangle glaucomaArch OphthalmolYear: 200212071472012049575  
Gao F,Miller JP,Miglior S,Beiser JA,Torri V,Kass MA,Gordon MO,A joint model for prognostic effect of biomarker variability on outcomes: longterm intraocular pressure (IOP) fluctuation on the risk of developing primary openangle glaucoma (POAG)JP Journal of BiostatisticsYear: 201152739622180704  
Lo Y,Mendell NR,Rubin DB,Testing the number of components in a normal mixtureBiometrikaYear: 20018876777810.1093/biomet/88.3.767  
ProustLima C,Taylor JMG,Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approachBiostatisticsYear: 20091053554910.1093/biostatistics/kxp00919369642  
Lin H,Turnbull BW,Mcculloch CE,Slate EH,Latent class models for joint analysis of longitudinal biomarker and event process data: application to longitudinal prostatespecific antigen readings and prostate cancerJ Am Stat AssocYear: 200297536510.1198/016214502753479220  
Muthén LK,Muthén BO,Mplus User’s guideYear: 1998–2010SixthLos Angeles, CA: Muthén & Muthén  
R Core TeamR: a language and environment for statistical computingYear: 2012Vienna, Austria: R Foundation for Statistical Computing http://www.Rproject.org/ ISBN 3900051070.  
Miglior S,Torri V,Zeyen T,Pfeiffer N,CunhaVaz J,Adamsons I,Intercurrent factors associated with the development of openangle glaucoma in the European glaucoma prevention studyAm J OphthalmolYear: 200714426627510.1016/j.ajo.2007.04.04017543874  
Harrell FE Jr,Lee KL,Mark DB,Tutorial in biostatistics multivariate prognostic models: Issues in developing models, evaluation assumptions and adequacy, and measuring and reducing errorsStat MedYear: 19961536138710.1002/(SICI)10970258(19960229)15:4<361::AIDSIM168>3.0.CO;248668867  
NouriMahdavi K,Hoffman D,Coleman AL,et al. Advanced glaucoma intervention study. Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention studyOphthalmologyYear: 200411191627163510.1016/j.ophtha.2004.02.01715350314  
Bengtsson BL,Leske MC,Hyman L,Heijl A,Early Manifest Glaucoma Trial GroupFluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trialOphthalmologyYear: 200711420520910.1016/j.ophtha.2006.07.06017097736  
Caprioli J,Coleman AL,Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention studyOphthalmologyYear: 20081151123112910.1016/j.ophtha.2007.10.03118082889  
Medeiros FA,Weinreb RN,Zangwill LM,et al. Longterm intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucomaOphthalmologyYear: 200811593494010.1016/j.ophtha.2007.08.01217936908  
Laird NM,Ware JH,Randomeffects models for longitudinal dataBiometricsYear: 19823896397410.2307/25298767168798  
Jones BL,Nagin DS,Advances in groupbased trajectory modeling and a SAS procedure for estimating themSociological Methods & ResearchYear: 2007353542571  
Henderson R,Diggle P,Dobson A,Joint modeling of longitudinal measurements and event time dataBiostatisticsYear: 2000446548012933568  
Vonesh EF,Greene T,Schluchter MD,Shared parameter models for the joint analysis of longitudinal data and event timesStatistics in MedicineYear: 20062514316310.1002/sim.224916025541  
Van Houwelingen HC,Dynamic prediction by landmarking in event history analysisScand J StatistYear: 200734708510.1111/j.14679469.2006.00529.x 
Figures
Tables
Summary statistics of baseline predictors and followup data for OHTS and EGPS, where categorical variables are summarized as counts and proportions, while the continuous variables are summarized in means and standard deviations (SD).
Variables  OHTS (N = 1600)  EGPS (N = 971) 

Baseline predictors



TRT

795 (49.7%)

487 (50.2%)

Male

687 (42.9%)

445 (45.8%)

Black

396 (24.8%)

1 (0.1%)

AGE (decades)

5.56 (0.96)

5.70 (1.02)

IOP0 (mmHg)

24.9 (2.69)

23.4 (1.62)

CCT (μm)

572.6 (38.5)

573.3 (37.5)

PSD (dB)

1.91 (0.21)

2.00 (0.52)

VCD

0.39 (0.19)

0.32 (0.14)

BB

71 (4.4%)

64 (6.6%)

CHB

190 (11.9%)

66 (6.8%)

DM

188 (11.8%)

55 (5.7%)

Heart

99 (6.2%)

109 (11.2%)

HBP

606 (37.9%)

279 (28.7%)

Postrandomization IOP



Mean (mmHg)

21.44 (3.45)

19.73 (2.57)

SD (mmHg)

2.27 (1.04)

2.22 (1.03)

Median #visits (minmax)

13 (2–16)

9 (2–10)

POAG  146 (9.1%)  107 (11.0%) 
Fitting statistics of 7 competing models that are only different in the number of latent classes
# latent classes (G)

OHTS

EGPS



BIC  LMRLRT*  Minimal class size  BIC  LMRLRT  Minimal class size  
2

97097

<0.001

47%

39235

<0.001

44%

3

94219

0.002

24%

38395

0.001

14%

4

92922

0.609

14%

38109

0.005

11%

5

92107

0.003

13%

37870

0.009

12%

6

91644

0.042

10%

37760

0.452

9%

7

91289

0.147

7%

37682

0.060

5%

8  91045  0.406  6%  37608  0.011  4% 
* LoMendellRubin likelihood ratio test, with a smaller pvalue favoring the Gclass model over the model with G1 classes (null hypothesis).
Observed proportions of POAG, as well as estimated hazard ratios (HR) and 95% confidence intervals (CI) for POAG development in the unconditional LCAs for the OHTS and EGPS data, where the HR and 95% CI were based on 1000 bootstrapping samples to account for the uncertainty in the latent class membership
Latent class

OHTS

EGPS



POAG%  HR  95% CI  POAG%  HR  95% CI  
1

5.9%

1.00



8.3%

1.00



2

3.9%

0.59

0.37  0.88

10.2%

1.28

0.76  2.06

3

4.3%

0.83

0.57  1.14

8.7%

1.13

0.73  1.65

4

10.1%

1.87

1.32  2.57

10.5%

1.40

0.85  2.18

5

11.4%

1.93

1.50  2.46

19.4%

2.66

1.92  3.69

6  31.2%  5.61  4.46  7.08 
Distribution of the randomization groups across latent classes, where the latent classes were based on the most likely posterior class probability from the optimal unconditional LCAs for the OHTS and EGPS data
Latent class

OHTS

EGPS



Observation  Treatment  Placebo  Treatment  
1

15 (1.9%)

191 (24.0%)

113 (23.3%)

143 (29.4%)


2

67 (8.3%)

385 (48.4%)

69 (14.3%)

112 (23.0%)


3

226 (28.1%)

106 (13.3%)

162 (33.5%)

136 (27.9%)


4

55 (6.8%)

84 (10.6%)

64 (13.2%)

63 (12.9%)


5

279 (34.7%)

19 (2.4%)

76 (15.7%)

33 (6.8%)


6

163 (20.2%)

10 (1.3%)




Total  805 (100%)  795 (100%)  484 (100%)  487 (100%) 
Estimated parameters of the conditional LCAs in the OHTS and EGPS data
OHTS



Variables

Parameters for IOP change and the effects of covariates on class membership

Effects on POAG


Class 1  Class2 (Ref.)  Class 3  Class 4  Class 5  Class 6  
Class Size IOP Change

14.2%

27.1%

21.1%

9.1%

17.6%

10.9%


I

17.58(0.20)^{#}

19.83(0.21)^{#}

22.30(0.21)^{#}

22.82(0.79)^{#}

24.74(0.22)#

27.70(0.28)^{#}



L

−0.57(0.08)^{#}

−0.53(0.06)^{#}

−0.47(0.09)^{#}

−0.95(0.30)^{#}

−0.20(0.09)*

0.16(0.17)



Q

0.06(0.01)^{#}

0.05(0.01)^{#}

0.05(0.01)^{#}

0.07(0.04)

0.02(0.02)

−0.05(0.03)



V

4.36(0.27)^{#}

4.30(0.32)^{#}

4.80(0.25)^{#}

16.07(1.46)^{#}

4.66(0.31)#

12.15(1.15)^{#}



Covariates








Intercept

−2.64(0.63)^{#}


2.08(0.47)^{#}

−0.06(0.47)

2.35(0.54)^{#}

1.04(0.61)



TRT

1.60(0.66)^{*}



−3.25(0.35)^{#}

−2.19(0.63)^{#}

−5.98(0.56)^{#}

−6.46(0.70)^{#}

0.16(0.29)

MALE

0.25(0.23)



−0.99(0.24)^{#}

0.24(0.27)

−0.68(0.28)^{*}

−0.22(0.30)

0.23(0.19)

RACEB

−0.10(0.27)



−0.37(0.30)

0.75(0.31)^{*}

−0.91(0.34)^{*}

0.05(0.37)

−0.05(0.24)

AGE

0.06(0.12)



−0.01(0.12)

0.08(0.16)

−0.05(0.14)

0.13(0.15)

0.18(0.09) ^{*}

IOP0

−0.79(0.18)^{#}



0.21(0.22)

1.03(0.36)^{*}

0.89(0.18)^{#}

1.73(0.22)^{#}

−0.10(0.11)

CCT

−0.35(0.12)^{*}



0.18(0.11)

−0.08(0.17)

0.14(0.13)

0.09(0.16)

−0.64(0.13)^{#}

PSD

0.13(0.11)



0.04(0.11)

0.08(0.13)

0.17(0.13)

0.12(0.15)

0.23(0.10)^{*}

VCD

0.06(0.11)



−0.08(0.12)

−0.15(0.17)

−0.10(0.13)

−0.09(0.15)

0.60(0.10)^{#}

BB

−0.60(0.48)



−0.37(0.61)

^{**}

−0.30(0.62)

−1.21(0.77)

0.19(0.57)

CHB

−0.19(0.37)



−0.32(0.42)

0.47(0.45)

−0.42(0.44)

−0.50(0.49)

0.09(0.31)

DM

−0.23(0.35)



0.22(0.32)

−0.71(0.45)

0.23(0.36)

0.64(0.40)

−1.67(0.53)^{*}

HEART

0.70(0.44)



0.10(0.49)

0.43(0.56)

−0.09(0.56)

−0.48(0.73)

0.71(0.29)^{*}

HBP

0.47(0.24)^{*}



0.40(0.27)

0.06(0.34)

0.41(0.30)

0.66(0.33)^{*}

0.08(0.22)

EGPS


Variables

Parameters for IOP change and the effects of covariates on class membership

Effects on POAG




Class1 (Ref.)

Class 2

Class 3

Class 4

Class 5



Class Size IOP Change

26.3%

20.1%

29.3%

12.9%

11.4%



I

18.66(0.25) ^{#}

18.24(0.18)^{#}

21.24(0.20)^{#}

21.85(0.47)^{#}

24.33(0.34)^{#}




L

−0.34(0.14)^{*}

−1.29(0.18)^{#}

−0.25(0.11)^{*}

−1.76(0.28)^{#}

0.06(0.26)




Q

0.05(0.03)

0.11(0.04)*

0.02(0.03)

0.02(0.07)

−0.08(0.07)




V

3.79(0.23)^{#}

3.75(0.25)^{#}

4.59(0.24)^{#}

7.12(0.85)^{#}

12.17(1.32)^{#}




Covariates








Intercept



−0.84(0.33)^{*}

0.30(0.28)

−0.85(0.58)

−0.71(0.34)^{*}




TRT



0.36(0.27)

−0.65(0.23)^{*}

−0.58(0.37)

−1.79(0.37)^{#}

−0.01(0.21)


MALE



−0.35(0.29)

0.14(0.23)

0.18(0.40)

0.38(0.33)

−0.24(0.22)


Black














AGE



−0.09(0.16)

0.01(0.13)

0.40(0.23)

0.45(0.20)^{*}

0.16(0.10)


IOP0



−0.61(0.24)^{*}

0.82(0.17)^{#}

1.24(0.24)^{#}

1.79(0.23)^{#}

0.11(0.13)


CCT



−0.33(0.13)^{*}

−0.14(0.12)

−0.43(0.15)^{*}

0.09(0.15)

−0.36(0.12)^{*}


PSD



0.27(0.16)

−0.23(0.14)

−0.18(0.24)

−0.41(0.23)

0.18(0.09)^{*}


VCD



−0.13(0.17)

−0.03(0.13)

0.72(0.26)^{*}

0.17(0.16)

0.46(0.12)^{#}


BB



−0.17(0.50)

−0.82(0.52)

^{**}

−0.58(0.69)

−0.07(0.41)


CHB



−0.10(0.56)

−0.97(0.52)

0.89(1.03)

−1.22(0.79)

−0.28(0.47)


DM



−0.46(0.52)

0.12(0.45)

−1.32(1.27)

0.82(0.81)

−0.18(0.54)


HEART



0.78(0.41)

0.11(0.44)

−0.83(0.77)

−0.79(0.61)

0.74(0.32)^{*}


HBP    0.02(0.36)  0.53(0.30)  −1.27(0.90)  0.11(0.54)  0.24(0.26) 
*: p < 0.05; #: p < 0.001; **: Not estimable due to zero count of beta blocker use in the given class.
Sensitivity analysis comparing the overall predictive accuracy (measured as Cindex and Calibration Chisquare statistics) for LCAs with different model specifications
Model

Model Features

C index

Calibration Chisquare



OHTS  EGPS  OHTS  EGPS  
0

Cox mode with baseline factors only

0.778

0.706

5.0

2.1

1

LCA with a quadratic withinclass functional form

0.821

0.719

11.3

7.0

2

LCA with a linear withinclass functional form

0.825

0.720

10.2

4.9

3  LCA with a constant withinclass functional form  0.823  0.727  10.5  13.5 
Article Categories:
Keywords: Latent class analysis, Longitudinal data, Timedependent covariate, Prediction model, Survival data, Primary openangle glaucoma, Intraocular pressure fluctuation. 
Previous Document: LuxU connects quorum sensing to biofilm formation in Vibrio fischeri.
Next Document: Listening to Placebo in Clinical Trials for Female Sexual Dysfunction.